01/10/2025
8:23 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/27/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
12:34 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
8:05 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
8:10 AM | CRISPR Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/15/2024
5:00 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
5:00 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
5:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
4:22 PM | CRISPR Therapeutics (Filer)
| Form S-3ASR | |
06/24/2024
4:35 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:06 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:50 PM | Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:50 PM | CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:14 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:15 PM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:24 PM | CRISPR Therapeutics (Subject)
Kulkarni Samarth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
10:58 AM | Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
04/09/2024
3:42 PM | CRISPR Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
3:43 PM | CRISPR Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024
3:47 PM | CRISPR Therapeutics (Filer)
| Form ARS | |
03/27/2024
3:30 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A | |
03/27/2024
3:30 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:45 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:02 PM | CRISPR Therapeutics (Subject)
Morrow Phuong Khanh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:43 PM | CRISPR Therapeutics (Subject)
Kulkarni Samarth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:45 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:39 PM | CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:45 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Wall St turns to THIS catalyst after Trump’s inauguration (Ad) Wall Street is already looking past Trump…
To a new catalyst on the near horizon that could be even bigger than his inauguration.
As soon as January 29th… So please watch this video now before the hammer falls and it’s too late. |
02/21/2024
6:45 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
6:50 AM | CRISPR Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:30 PM | CRISPR Therapeutics (Subject)
Kulkarni Samarth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
4:22 PM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:44 AM | CRISPR Therapeutics (Filer)
| Form 424B5 | |
02/13/2024
5:30 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
5:30 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
5:22 PM | CRISPR Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G/A | |
02/05/2024
5:08 AM | CRISPR Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G/A | |
01/31/2024
4:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
